Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019 2019-10-21 14:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 2019-10-18 20:30
China Biologic Special Committee Retains Financial Advisor and Legal Counsel 2019-10-17 20:00
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH 2019-10-16 18:00
Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis 2019-10-15 05:58
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5 2019-10-04 13:40
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US 2019-10-02 12:01
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval 2019-10-01 04:00
Yuyu Pharma Unveils New Corporate Logo 2019-09-30 21:00
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019 2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended 2019-09-30 13:27
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
China Biologic Forms Special Committee to Review "Going Private" Proposal 2019-09-24 20:00
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Multiple Cancer Types 2019-09-23 19:00
CARsgen Announces Investigational CAR-T Therapy CT053 Granted PRIME Eligibility by the European Medicines Agency 2019-09-23 18:00
1 119 120 121 122 123 158